The Association of British Clinical Diabetologists

Impact of Semaglutide on Body Composition in Adults with Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Read more about Impact of Semaglutide on Body Composition in Adults with Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Rhodri King¹; John P.H. Wilding²; Rachel L. Batterham³; Salvatore Calanna⁴; Luc F. Van Gaal⁵; Barbara M. McGowan⁶; Julio Rosenstock⁷; Marie T.D. Tran⁴; Sean Wharton⁸; Koutaro Yokote⁹; Niels Zeuthen⁴; Robert F. Kushner¹⁰

Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for patients with type 1 diabetes

Read more about Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for patients with type 1 diabetes

Callum WD Innes*, David E Henshall†*, Blair Wilson, Michael Poon, Steven D Morley, Stuart A Ritchie

NHS Lothian and The University of Edinburgh

Introducing a local HHS protocol at the beginning of the COVID-19 pandemic: a review of HHS management against national standards before and after

Read more about Introducing a local HHS protocol at the beginning of the COVID-19 pandemic: a review of HHS management against national standards before and after

Haggarty RH; Huang FH; Kernohan AK; Leak SL; O’Doherty EO; McAllister RM; McNeilly JM

Greater Glasgow and Clyde (GG&C)

Use of a simplified local guideline to optimise “front door” management of diabetes and hyperglycaemia in patients with COVID-19

Read more about Use of a simplified local guideline to optimise “front door” management of diabetes and hyperglycaemia in patients with COVID-19

Fetherston E; Tee SA; Kwok ML; Artham S; Carey PE; Nayar R; Bishop D; Joshi A.

Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust

Hyperglycaemic emergencies during the COVID-19 pandemic in East London, one of the worse affected areas in the UK

Read more about Hyperglycaemic emergencies during the COVID-19 pandemic in East London, one of the worse affected areas in the UK

A Entwistle, A E Edwards, S V Gelding, K Gunganah

Department of Diabetes and Endocrinology, Newham University Hospital, Barts Health NHS Trust, London, UK

Cortisol measurement post steroids (Dexamethasone) treatment for COVID-19

Read more about Cortisol measurement post steroids (Dexamethasone) treatment for COVID-19

Randa Eltayeb¹, Oliver Marwood², Shaun Kellam³, HL Simpson¹

1 Dept of Diabetes and Endocrinology
2 UCL Medical School
3 Department of Critical Care, University College Hospital, London,(UK)

One-third of diabetes patients with hyperkalaemia during acute admission have reninaldosterone angiotensin system (RAAS) antagonists discontinued by hospital discharge

Read more about One-third of diabetes patients with hyperkalaemia during acute admission have reninaldosterone angiotensin system (RAAS) antagonists discontinued by hospital discharge

Hugh Logan Ellis¹ , Claire Sharpe¹ , Philip Kelly¹ , Mohammad Al-Agil¹ , Anthony Shek² , James Teo¹ , Martin Whyte¹

1 King’s College Hospital, London UK
2 King’s College London, London UK

The absence of diabetic autoantibodies when routinely tested in adult-onset type 1 diabetes is associated with a high prevalence of treatment change & successful insulin cessation

Read more about The absence of diabetic autoantibodies when routinely tested in adult-onset type 1 diabetes is associated with a high prevalence of treatment change & successful insulin cessation

R. Eason^1,2, A. Hill^1,2, B. Shields¹, P. Tippett¹, T. McDonald³, A. Hattersley^1,2, R. Oram^1,2, B. Knight^1,2, M. Weedon^1,2, N. Thomas^1,2, A. Jones^1,2

Glycaemic outcomes associated with do-it-yourself artificial pancreas systems (DIYAPS): Initial insights from the Association of British Clinical Diabetologists (ABCD) DIYAPS audit programme

Read more about Glycaemic outcomes associated with do-it-yourself artificial pancreas systems (DIYAPS): Initial insights from the Association of British Clinical Diabetologists (ABCD) DIYAPS audit programme

TSJ Crabtree^1,2,3; S Hussain^4,5,6; B Mendis⁷; T Gazis⁷; R Herring⁸; I Idris^1,2, REJ Ryder³; EG Wilmot^1,2.

The impact of empagliflozin dose on HbA1c & weight outcomes at 6 & 12 months: updated analysis from the ABCD empagliflozin audit programme

Read more about The impact of empagliflozin dose on HbA1c & weight outcomes at 6 & 12 months: updated analysis from the ABCD empagliflozin audit programme

TSJ Crabtree^1,2,3, A Gallagher⁴, I Gallen⁵, A Melvin⁶, N Morrish⁶, J Elliott⁷, A Bickerton⁸, REJ Ryder¹ on behalf of ABCD empagliflozin audit contributors

Subscribe to The Association of British Clinical Diabetologists